Bain Capital Life Sciences Investors, LLC Acadia Pharmaceuticals Inc Transaction History

Bain Capital Life Sciences Investors, LLC

  • $557 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$14.2 - $18.63 $1.29 Million - $1.69 Million
90,879 Added 14.89%
701,402 $11.2 Million
Q3 2022

Nov 14, 2022
BUY
$14.11 - $18.27 $141,100 - $182,700
10,000 Added 1.67%
610,523 $9.99 Million
Q2 2022

Aug 15, 2022
BUY
$13.01 - $27.22 $7.81 Million - $16.3 Million
600,523 New
600,523 $8.46 Million

Others Institutions Holding ACAD

# of Institutions
279
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email